Daniel Holley
Research Subjects
Daniel Holley has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Tom Zaubler
Clinical Operation, NeuroFlow, Philadelphia, USA
3 shared publicationsAmanda Brooks
Clinical Operation, NeuroFlow, Philadelphia, USA
2 shared publications- Amanda Brooks
NeuroFlow, Philadelphia, United States
2 shared publications Andrew S. Fox
2 shared publications- Andrew S. Fox
University of California, Davis
2 shared publications As Fox
University of California, Davis, Department of Psychology
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-14
Evaluating Generative Pretrained Transformer (GPT) models for suicide risk assessment in synthetic patient journal entries
Over 700,000 individuals die by suicide globally each year, with rapid progression from suicidal ideation (SI) to attempt often precluding opportunities for intervention. Digital behavioral health (DBH) platforms offer novel means of collecting SI indicators outside the clinic, but the actionable utility of these data may be limited by clinician-dependent workflows such as reviewing patients’ journaling exercises for signs of SI. Large language models (LLMs) provide a methodology to streamline this task by rapidly risk-stratifying text based on the presence and severity of SI; however, this application has yet to be reliably evaluated. To test this approach, we first generated and validated a corpus of 125 synthetic journal responses to prompts from a real-world DBH platform. The responses varied on the presence and severity of suicidal ideation, readability, length, use of emojis, and other common language features, allowing for over 1 trillion feature permutations. Next, five collaborating behavioral health experts worked independently to stratify these responses as no-, low-, moderate-, or high-risk SI. Finally, we risk-stratified the responses using several tailored implementations of OpenAI’s Generative Pretrained Transformer (GPT) models and compared the results to those of our raters. Using clinician consensus as “ground truth,” our ensemble LLM performed significantly above chance (30.38%) in exact risk-assessment agreement (65.60%; χ2 = 86.58). The ensemble model also aligned with 92% of clinicians’ “do/do not intervene” decisions (Cohen’s Kappa = 0.84) and achieved 94% sensitivity and 91% specificity in that task. Additional results of precision-recall, time-to-decision, and cost analyses are reported. While further testing and exploration of ethical considerations remain critical, our results offer preliminary evidence that LLM-powered risk stratification can serve as a powerful and cost-effective tool to enhance suicide prevention frameworks.
- 1 August 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-14
Open AccessEvaluating Generative Pretrained Transformer (GPT) models for suicide risk assessment in synthetic patient journal entries
Over 700,000 individuals die by suicide globally each year, with rapid progression from suicidal ideation (SI) to attempt often precluding opportunities for intervention. Digital behavioral health (DBH) platforms offer novel means of collecting SI indicators outside the clinic, but the actionable utility of these data may be limited by clinician-dependent workflows such as reviewing patients’ journaling exercises for signs of SI. Large language models (LLMs) provide a methodology to streamline this task by rapidly risk-stratifying text based on the presence and severity of SI; however, this application has yet to be reliably evaluated. To test this approach, we first generated and validated a corpus of 125 synthetic journal responses to prompts from a real-world DBH platform. The responses varied on the presence and severity of suicidal ideation, readability, length, use of emojis, and other common language features, allowing for over 1 trillion feature permutations. Next, five collaborating behavioral health experts worked independently to stratify these responses as no-, low-, moderate-, or high-risk SI. Finally, we risk-stratified the responses using several tailored implementations of OpenAI’s Generative Pretrained Transformer (GPT) models and compared the results to those of our raters. Using clinician consensus as “ground truth,” our ensemble LLM performed significantly above chance (30.38%) in exact risk-assessment agreement (65.60%; χ2 = 86.58). The ensemble model also aligned with 92% of clinicians’ “do/do not intervene” decisions (Cohen’s Kappa = 0.84) and achieved 94% sensitivity and 91% specificity in that task. Additional results of precision-recall, time-to-decision, and cost analyses are reported. While further testing and exploration of ethical considerations remain critical, our results offer preliminary evidence that LLM-powered risk stratification can serve as a powerful and cost-effective tool to enhance suicide prevention frameworks.
- Open Access
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e52764
mHealth-Augmented Care for Reducing Depression Symptom Severity Among Patients With Chronic Pain: Exploratory, Retrospective Cohort Study
Background: Depression and chronic pain are commonly comorbid, mutually reinforcing, and debilitating. Emerging approaches to mobile behavioral health care (mHealth) promise to improve outcomes for patients with comorbid depression and chronic pain by integrating with existing care models to bolster support and continuity between clinical visits; however, the evidence base supporting the use of mHealth to augment care for this patient population is limited. Objective: To develop an evidence base that sets the stage for future research, we aimed to explore the associations between changes in depression severity and various integrated care models, with and without mHealth augmentation, among patients with comorbid depression and nonmalignant chronic pain. Methods: Our team leveraged retrospective, real-world data from 3837 patients with comorbid depression and nonmalignant chronic pain who received integrated behavioral health care (IBH) at a subspecialty pain clinic. We analyzed one IBH-only, non-mHealth cohort (n=2765), an mHealth-augmented cohort (n=844), and a collaborative care (CoCM)+mHealth cohort (n=136), which were supported by the NeuroFlow mHealth platform, and a pre-CoCM mHealth cohort (n=92), which was supported by the mHealth platform for 3 months prior to beginning the chronic pain treatment. We evaluated changes in depression severity between treatment cohorts via longitudinal analyses of both clinician- and mHealth-administered Patient Health Questionnaire-9 (PHQ-9) assessments. Results: mHealth-augmented integrated care led to significantly greater proportions of patients reaching clinical benchmarks for reduction (725/844, 86% vs 2112/2765, 76%), response (689/844, 82% vs 2027/2765, 73%), and remission (629/844, 75% vs 1919/2765, 69%) compared with integrated care alone. Furthermore, hierarchical regression modeling revealed that patients who received mHealth-augmented psychiatric CoCM experienced the greatest sustained reductions in on-average depression severity compared with other cohorts, irrespective of clinical benchmarks. In addition, patients who engaged with an mHealth platform before entering CoCM experienced a 7.2% reduction in average depression severity before starting CoCM treatment. Conclusions: Our findings suggest that mHealth platforms have the potential to improve treatment outcomes for patients with comorbid chronic pain and depression by providing remote measurement–based care, tailored interventions, and improved continuity between appointments. Moreover, our study set the stage for further research, including randomized controlled trials to evaluate causal relationships between mHealth engagement and treatment outcomes in integrated care settings.
- 10 January 2025
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 13 (1) , e52764
Open AccessmHealth-Augmented Care for Reducing Depression Symptom Severity Among Patients With Chronic Pain: Exploratory, Retrospective Cohort Study
Background: Depression and chronic pain are commonly comorbid, mutually reinforcing, and debilitating. Emerging approaches to mobile behavioral health care (mHealth) promise to improve outcomes for patients with comorbid depression and chronic pain by integrating with existing care models to bolster support and continuity between clinical visits; however, the evidence base supporting the use of mHealth to augment care for this patient population is limited. Objective: To develop an evidence base that sets the stage for future research, we aimed to explore the associations between changes in depression severity and various integrated care models, with and without mHealth augmentation, among patients with comorbid depression and nonmalignant chronic pain. Methods: Our team leveraged retrospective, real-world data from 3837 patients with comorbid depression and nonmalignant chronic pain who received integrated behavioral health care (IBH) at a subspecialty pain clinic. We analyzed one IBH-only, non-mHealth cohort (n=2765), an mHealth-augmented cohort (n=844), and a collaborative care (CoCM)+mHealth cohort (n=136), which were supported by the NeuroFlow mHealth platform, and a pre-CoCM mHealth cohort (n=92), which was supported by the mHealth platform for 3 months prior to beginning the chronic pain treatment. We evaluated changes in depression severity between treatment cohorts via longitudinal analyses of both clinician- and mHealth-administered Patient Health Questionnaire-9 (PHQ-9) assessments. Results: mHealth-augmented integrated care led to significantly greater proportions of patients reaching clinical benchmarks for reduction (725/844, 86% vs 2112/2765, 76%), response (689/844, 82% vs 2027/2765, 73%), and remission (629/844, 75% vs 1919/2765, 69%) compared with integrated care alone. Furthermore, hierarchical regression modeling revealed that patients who received mHealth-augmented psychiatric CoCM experienced the greatest sustained reductions in on-average depression severity compared with other cohorts, irrespective of clinical benchmarks. In addition, patients who engaged with an mHealth platform before entering CoCM experienced a 7.2% reduction in average depression severity before starting CoCM treatment. Conclusions: Our findings suggest that mHealth platforms have the potential to improve treatment outcomes for patients with comorbid chronic pain and depression by providing remote measurement–based care, tailored interventions, and improved continuity between appointments. Moreover, our study set the stage for further research, including randomized controlled trials to evaluate causal relationships between mHealth engagement and treatment outcomes in integrated care settings.
- Open Access
- 8 January 2025
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 11 (3) , 1-15
Predicting Risk of Suicidal Ideation with Digital Ecological Momentary Assessment of Sleep, Stress, Mood, and Pain: Implications for Tech-Enabled Suicide Prevention
- 8 January 2025
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 11 (3) , 1-15
Open AccessPredicting Risk of Suicidal Ideation with Digital Ecological Momentary Assessment of Sleep, Stress, Mood, and Pain: Implications for Tech-Enabled Suicide Prevention
- Open Access
- 7 February 2024
- Published by Ubiquity Press, Ltd. in Computational Psychiatry
- Vol. 8 (1) , 85-91
Temporal Dynamics of Uncertainty Cause Anxiety and Avoidance
Alfred Hitchcock, film director and “Master of Suspense,” observed that terror is not driven by a negative event, but “only in the anticipation of it.” This observation is not restricted to the movies: Anxiety builds when we anticipate uncertain negative events, and heightened reactivity during uncertain threat anticipation is a transdiagnostic marker of anxiety (Grupe & Nitschke, 2013; Holley & Fox, 2022; Hur et al., 2020; Krain et al., 2008; Simmons et al., 2008; Yassa et al., 2012). Here, we manipulate the temporal dynamics of an uncertain threat to demonstrate how the evolving expectation of threat can lead people to forgo rewards and experience fear/anxiety. Specifically, we show that increased “hazard rate,” which can build during periods of uncertainty, promotes a tendency to avoid threatening contexts while increasing fear/anxiety. These results provide insight into why the anticipation of temporally uncertain threats elicits fear/anxiety, and reframe the underlying causes of related psychopathology.
- 7 February 2024
- Published by Ubiquity Press, Ltd. in Computational Psychiatry
- Vol. 8 (1) , 85-91
Open AccessTemporal Dynamics of Uncertainty Cause Anxiety and Avoidance
Alfred Hitchcock, film director and “Master of Suspense,” observed that terror is not driven by a negative event, but “only in the anticipation of it.” This observation is not restricted to the movies: Anxiety builds when we anticipate uncertain negative events, and heightened reactivity during uncertain threat anticipation is a transdiagnostic marker of anxiety (Grupe & Nitschke, 2013; Holley & Fox, 2022; Hur et al., 2020; Krain et al., 2008; Simmons et al., 2008; Yassa et al., 2012). Here, we manipulate the temporal dynamics of an uncertain threat to demonstrate how the evolving expectation of threat can lead people to forgo rewards and experience fear/anxiety. Specifically, we show that increased “hazard rate,” which can build during periods of uncertainty, promotes a tendency to avoid threatening contexts while increasing fear/anxiety. These results provide insight into why the anticipation of temporally uncertain threats elicits fear/anxiety, and reframe the underlying causes of related psychopathology.
- Open Access
- 1 January 2024
- Published by Innovative Healthcare Institute in Innovations in Digital Health, Diagnostics, and Biomarkers
- Vol. 4 (2024) , 6-8
Using Natural Language Processing to Detect Suicidal Ideation and Prompt Urgent Interventions: A Retrospective Database Study
Suicide claimed over 48,000 lives in the United States in 2021 and is a leading cause of death among Americans aged 10–54.[1] Suicidal ideation (SI) predicts suicidal behavior[2] and is commonly evaluated in healthcare settings via intake screenings and psychometric assessments.[3] Nevertheless, the timely detection of SI is challenging: Progression from the first instance of SI to the first suicide attempt is often rapid,[4] and roughly half of all adults who die by suicide have contact with a healthcare provider within 1 month before their death.[5] This disconnect underscores the need for asynchronous approaches that complement existing SI-detection frameworks and enable low-latency interventions. Mobile healthcare (mHealth) technologies promise to improve SI detection and enable timely interventions by remotely administering prescribed assessments.[6] However, remote assessments alone may fail to detect SI among patients whose assessment compliance has lapsed and those who are compliant but do not indicate SI.Intriguingly, mHealth platforms are well-suited to elicit free-form text entries from patients and remotely screen those entries for SI indicators via natural language processing (NLP)—a field of computer science that enables analysis of ingested text through the application of linguistic, statistical, and machine-learning principles.[7] Here, we used retrospective real-world data from patients who engaged in journaling exercises via the prescribed mHealth platform NeuroFlow[6] to show that an asynchronous NLP tokenization[7] protocol can augment the Patient Health Questionnaire-9[2] (PHQ9) by detecting SI in patients who have either fallen out of assessment compliance or who did not indicate SI in their most recent PHQ9. The NLP protocol leveraged keyword detection from a continuously refined SI lexicon, and clinicians reviewed alert-generating text entries to enable further refinement.We performed a retrospective database study of data collected in the course of routine healthcare operations from 425 patients (316 women, 86 men, 1 transgender, and 22 individuals who did not disclose or indicated “other”; mean [SD] age = 41.67 [15.22] years) across various national insurance payors, healthcare providers, employers, and government/military clients who used the mHealth platform to supplement patient care. Patients were selected if they had been flagged via asynchronous NLP screenings as having expressed SI in free-form text responses to platform-administered journaling prompts (see Supplemental Table, available online).This study was conducted in accordance with the principles of the Declaration of Helsinki. It was exempted from oversight and waived for informed consent following a review by Advarra’s Center for IRB Intelligence, which determined that the study constitutes secondary research as defined in 45 CFR 46.104(d)(4).For each patient’s first instance of NLP-detected SI, we evaluated the prior 30 days for PHQ9 compliance. When compliance was met, we evaluated Question 9 (Q9) and interpreted responses greater than 0 as indicative of SI. Question 9 was as follows: “Over the last 2 weeks, how often have you been bothered by… Thoughts that you would be better off dead or of hurting yourself in some way?” The response set included not at all (0), several days (1), more than half the days (2), and nearly every day (3).Between January 8, 2020, and August 9, 2023, NLP screenings (Fig. 1) detected possible SI in 425 patients, 344 of whom were compliant with PHQ9 assessments. Of those compliant, 177 indicated SI on Q9 of their most recent assessments (mean PHQ9, SD = 18.45, 5.28), and 167 did not (8.42, 5.92). The remaining 81 of 425 patients were out of assessment compliance.The mHealth platform automatically sent an email containing evidence-based crisis support to each of these 425 patients within 2 minutes of SI detection. These emails included national and local crisis support resources and notification that a check-in would occur in the next 24 hours. The platform simultaneously transmitted an alert for each patient to a response team of mental health professionals trained in crisis intervention (supervised by licensed clinicians) who monitor the alert queue during normal business hours (09:00–20:00 EST). Responders evaluated each alert and attempted outreach to provide tailored interventions to patients determined to be in urgent crises. The median time from SI detection to attempted or completed intervention, including case-note logging, was 2 hours 12 minutes during business hours and 12 hours 27 minutes during off hours. During interventions, responders employed evidence-based suicide prevention strategies[8] by administering the Columbia-Suicide Severity Rating Scale (C-SSRS), initiating the Suicidal Assessment Five-Step Evaluation and Triage (SAFE-T) protocol, conducting safety planning, providing lethal means counseling, and orchestrating further care based on assessed risk. Of note, patients who triggered alerts during off hours received immediate platform-generated support as described above. All patients received platform-generated support focused on suicide risk mitigation and consisting of videos, handouts, and journaling exercises immediately after SI detection and periodically for the next 4 days.Limited case note availability due to evolving policies and cross-organizational data-sharing strictures is a weakness of our study. Our team performed outreach as described above for 23 of 425 patients who generated alerts, with the remainder serviced by external organizations whose data-sharing policies preclude retrospective case note analysis. Furthermore, even among the patients our team serviced, the mHealth platform’s data capture and retention policies before March 2022 limit our insights. Case notes were available for only 17 patients serviced by our organization (ie, patients who prompted...
- 1 January 2024
- Published by Innovative Healthcare Institute in Innovations in Digital Health, Diagnostics, and Biomarkers
- Vol. 4 (2024) , 6-8
Open AccessUsing Natural Language Processing to Detect Suicidal Ideation and Prompt Urgent Interventions: A Retrospective Database Study
Suicide claimed over 48,000 lives in the United States in 2021 and is a leading cause of death among Americans aged 10–54.[1] Suicidal ideation (SI) predicts suicidal behavior[2] and is commonly evaluated in healthcare settings via intake screenings and psychometric assessments.[3] Nevertheless, the timely detection of SI is challenging: Progression from the first instance of SI to the first suicide attempt is often rapid,[4] and roughly half of all adults who die by suicide have contact with a healthcare provider within 1 month before their death.[5] This disconnect underscores the need for asynchronous approaches that complement existing SI-detection frameworks and enable low-latency interventions. Mobile healthcare (mHealth) technologies promise to improve SI detection and enable timely interventions by remotely administering prescribed assessments.[6] However, remote assessments alone may fail to detect SI among patients whose assessment compliance has lapsed and those who are compliant but do not indicate SI.Intriguingly, mHealth platforms are well-suited to elicit free-form text entries from patients and remotely screen those entries for SI indicators via natural language processing (NLP)—a field of computer science that enables analysis of ingested text through the application of linguistic, statistical, and machine-learning principles.[7] Here, we used retrospective real-world data from patients who engaged in journaling exercises via the prescribed mHealth platform NeuroFlow[6] to show that an asynchronous NLP tokenization[7] protocol can augment the Patient Health Questionnaire-9[2] (PHQ9) by detecting SI in patients who have either fallen out of assessment compliance or who did not indicate SI in their most recent PHQ9. The NLP protocol leveraged keyword detection from a continuously refined SI lexicon, and clinicians reviewed alert-generating text entries to enable further refinement.We performed a retrospective database study of data collected in the course of routine healthcare operations from 425 patients (316 women, 86 men, 1 transgender, and 22 individuals who did not disclose or indicated “other”; mean [SD] age = 41.67 [15.22] years) across various national insurance payors, healthcare providers, employers, and government/military clients who used the mHealth platform to supplement patient care. Patients were selected if they had been flagged via asynchronous NLP screenings as having expressed SI in free-form text responses to platform-administered journaling prompts (see Supplemental Table, available online).This study was conducted in accordance with the principles of the Declaration of Helsinki. It was exempted from oversight and waived for informed consent following a review by Advarra’s Center for IRB Intelligence, which determined that the study constitutes secondary research as defined in 45 CFR 46.104(d)(4).For each patient’s first instance of NLP-detected SI, we evaluated the prior 30 days for PHQ9 compliance. When compliance was met, we evaluated Question 9 (Q9) and interpreted responses greater than 0 as indicative of SI. Question 9 was as follows: “Over the last 2 weeks, how often have you been bothered by… Thoughts that you would be better off dead or of hurting yourself in some way?” The response set included not at all (0), several days (1), more than half the days (2), and nearly every day (3).Between January 8, 2020, and August 9, 2023, NLP screenings (Fig. 1) detected possible SI in 425 patients, 344 of whom were compliant with PHQ9 assessments. Of those compliant, 177 indicated SI on Q9 of their most recent assessments (mean PHQ9, SD = 18.45, 5.28), and 167 did not (8.42, 5.92). The remaining 81 of 425 patients were out of assessment compliance.The mHealth platform automatically sent an email containing evidence-based crisis support to each of these 425 patients within 2 minutes of SI detection. These emails included national and local crisis support resources and notification that a check-in would occur in the next 24 hours. The platform simultaneously transmitted an alert for each patient to a response team of mental health professionals trained in crisis intervention (supervised by licensed clinicians) who monitor the alert queue during normal business hours (09:00–20:00 EST). Responders evaluated each alert and attempted outreach to provide tailored interventions to patients determined to be in urgent crises. The median time from SI detection to attempted or completed intervention, including case-note logging, was 2 hours 12 minutes during business hours and 12 hours 27 minutes during off hours. During interventions, responders employed evidence-based suicide prevention strategies[8] by administering the Columbia-Suicide Severity Rating Scale (C-SSRS), initiating the Suicidal Assessment Five-Step Evaluation and Triage (SAFE-T) protocol, conducting safety planning, providing lethal means counseling, and orchestrating further care based on assessed risk. Of note, patients who triggered alerts during off hours received immediate platform-generated support as described above. All patients received platform-generated support focused on suicide risk mitigation and consisting of videos, handouts, and journaling exercises immediately after SI detection and periodically for the next 4 days.Limited case note availability due to evolving policies and cross-organizational data-sharing strictures is a weakness of our study. Our team performed outreach as described above for 23 of 425 patients who generated alerts, with the remainder serviced by external organizations whose data-sharing policies preclude retrospective case note analysis. Furthermore, even among the patients our team serviced, the mHealth platform’s data capture and retention policies before March 2022 limit our insights. Case notes were available for only 17 patients serviced by our organization (ie, patients who prompted...
- Open Access
- 11 October 2023
- Published by Center for Open Science in PsyArXiv
Temporal Dynamics of Uncertainty Cause Anxiety and Avoidance
Alfred Hitchcock, a master of eliciting anxious apprehension, observed that suspense is not driven by a negative event, but “only in the anticipation of it.” This observation is not restricted to the movies: Anxiety builds when we anticipate uncertain negative events, and heightened reactivity during uncertain-threat anticipation is a transdiagnostic marker of anxiety. Here, we manipulate the temporal dynamics of an uncertain threat to demonstrate how the evolving expectation of threat can lead people to forgo rewards and experience anxiety. Specifically, we show that increased "hazard rate" can lead to anxiety and the associated tendency to avoid threatening contexts. These results provide insight into why the anticipation of temporally uncertain threats makes people anxious, and reframe the underlying causes of anxiety and anxiety-related psychopathology.
- 11 October 2023
- Published by Center for Open Science in PsyArXiv
Open AccessTemporal Dynamics of Uncertainty Cause Anxiety and Avoidance
Alfred Hitchcock, a master of eliciting anxious apprehension, observed that suspense is not driven by a negative event, but “only in the anticipation of it.” This observation is not restricted to the movies: Anxiety builds when we anticipate uncertain negative events, and heightened reactivity during uncertain-threat anticipation is a transdiagnostic marker of anxiety. Here, we manipulate the temporal dynamics of an uncertain threat to demonstrate how the evolving expectation of threat can lead people to forgo rewards and experience anxiety. Specifically, we show that increased "hazard rate" can lead to anxiety and the associated tendency to avoid threatening contexts. These results provide insight into why the anticipation of temporally uncertain threats makes people anxious, and reframe the underlying causes of anxiety and anxiety-related psychopathology.
- Open Access
Rhesus Infant Nervous Temperament Predicts Peri-Adolescent Central Amygdala Metabolism & Behavioral Inhibition Measured by a Machine-Learning Approach
Anxiety disorders affect millions of people worldwide and impair health, happiness, and productivity on a massive scale. Developmental research points to a connection between early-life behavioral inhibition and the eventual development of these disorders. Our group has previously shown that measures of behavioral inhibition in young rhesus monkeys ( Macaca mulatta ) predict anxiety-like behavior later in life. In recent years, clinical and basic researchers have implicated the central extended amygdala (EAc)—a neuroanatomical concept that includes the central nucleus of the amygdala (Ce) and the bed nucleus of the stria terminalis (BST)—as a key neural substrate for the expression of anxious and inhibited behavior. An improved understanding of how early-life behavioral inhibition relates to an increased lifetime risk of anxiety disorders—and how this relationship is mediated by alterations in the EAc—could lead to improved treatments and preventive strategies. In this study, we explored the relationships between infant behavioral inhibition and peri-adolescent defensive behavior and brain metabolism in 18 female rhesus monkeys. We coupled a mildly threatening behavioral assay with concurrent multimodal neuroimaging, and related those findings to various measures of infant temperament. To score the behavioral assay, we developed and validated UC-Freeze , a semi-automated machine-learning (ML) tool that uses unsupervised clustering to quantify freezing. Consistent with previous work, we found that heightened Ce metabolism predicted elevated defensive behavior (i.e., more freezing) in the presence of an unfamiliar human intruder. Although we found no link between infant inhibited temperament and peri-adolescent EAc metabolism or defensive behavior, we did identify infant nervous temperament as a significant predictor of peri-adolescent defensive behavior. Our findings suggest a connection between infant nervous temperament and the eventual development of anxiety and depressive disorders. Moreover, our approach highlights the potential for ML tools to augment existing behavioral neuroscience methods.
Open AccessRhesus Infant Nervous Temperament Predicts Peri-Adolescent Central Amygdala Metabolism & Behavioral Inhibition Measured by a Machine-Learning Approach
Anxiety disorders affect millions of people worldwide and impair health, happiness, and productivity on a massive scale. Developmental research points to a connection between early-life behavioral inhibition and the eventual development of these disorders. Our group has previously shown that measures of behavioral inhibition in young rhesus monkeys ( Macaca mulatta ) predict anxiety-like behavior later in life. In recent years, clinical and basic researchers have implicated the central extended amygdala (EAc)—a neuroanatomical concept that includes the central nucleus of the amygdala (Ce) and the bed nucleus of the stria terminalis (BST)—as a key neural substrate for the expression of anxious and inhibited behavior. An improved understanding of how early-life behavioral inhibition relates to an increased lifetime risk of anxiety disorders—and how this relationship is mediated by alterations in the EAc—could lead to improved treatments and preventive strategies. In this study, we explored the relationships between infant behavioral inhibition and peri-adolescent defensive behavior and brain metabolism in 18 female rhesus monkeys. We coupled a mildly threatening behavioral assay with concurrent multimodal neuroimaging, and related those findings to various measures of infant temperament. To score the behavioral assay, we developed and validated UC-Freeze , a semi-automated machine-learning (ML) tool that uses unsupervised clustering to quantify freezing. Consistent with previous work, we found that heightened Ce metabolism predicted elevated defensive behavior (i.e., more freezing) in the presence of an unfamiliar human intruder. Although we found no link between infant inhibited temperament and peri-adolescent EAc metabolism or defensive behavior, we did identify infant nervous temperament as a significant predictor of peri-adolescent defensive behavior. Our findings suggest a connection between infant nervous temperament and the eventual development of anxiety and depressive disorders. Moreover, our approach highlights the potential for ML tools to augment existing behavioral neuroscience methods.
- Open Access
- 2 June 2022
- Published by Center for Open Science in PsyArXiv
The Central Extended Amygdala Guides Survival-Relevant Tradeoffs for Action Selection
To thrive in challenging environments, individuals must pursue rewards while avoiding threats. Aberrant threat response is characteristic of anxiety disorders. Extensive studies in animals and humans have identified the central extended amygdala (EAc)—which includes the central nucleus of the amygdala (Ce) and the bed nucleus of the stria terminalis (BST)—as a conserved substrate for defensive behavior. These studies suggest the EAc influences defensive responding and assembles fearful and anxious states. One impact of these investigations has been the proliferation of a view that the EAc is fundamentally a defensive substrate. Recently, however, rodent studies have implicated the EAc in numerous appetitive and consummatory processes, yielding fresh insights into the microcircuitry of emotion-relevant response selection across various contexts. Coupled with the EAc’s centrality in a conserved network of brain regions that encode multisensory environmental and interoceptive information, these findings allude to a broader role for the EAc as an arbiter of survival-relevant tradeoffs for action selection. Understanding how the EAc optimizes these tradeoffs holds great promise in elucidating anxiety-related psychopathology.
- 2 June 2022
- Published by Center for Open Science in PsyArXiv
Open AccessThe Central Extended Amygdala Guides Survival-Relevant Tradeoffs for Action Selection
To thrive in challenging environments, individuals must pursue rewards while avoiding threats. Aberrant threat response is characteristic of anxiety disorders. Extensive studies in animals and humans have identified the central extended amygdala (EAc)—which includes the central nucleus of the amygdala (Ce) and the bed nucleus of the stria terminalis (BST)—as a conserved substrate for defensive behavior. These studies suggest the EAc influences defensive responding and assembles fearful and anxious states. One impact of these investigations has been the proliferation of a view that the EAc is fundamentally a defensive substrate. Recently, however, rodent studies have implicated the EAc in numerous appetitive and consummatory processes, yielding fresh insights into the microcircuitry of emotion-relevant response selection across various contexts. Coupled with the EAc’s centrality in a conserved network of brain regions that encode multisensory environmental and interoceptive information, these findings allude to a broader role for the EAc as an arbiter of survival-relevant tradeoffs for action selection. Understanding how the EAc optimizes these tradeoffs holds great promise in elucidating anxiety-related psychopathology.
- Open Access
- 1 January 2021
- Published by Elsevier in NeuroImage
- Vol. 225, 117518
Sharing voxelwise neuroimaging results from rhesus monkeys and other species with Neurovault
- 1 January 2021
- Published by Elsevier in NeuroImage
- Vol. 225, 117518
Open AccessSharing voxelwise neuroimaging results from rhesus monkeys and other species with Neurovault